TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.
Market News Page 26 of 158 • 3,926 articles
Why AI Stock Ceva Was Sliding Hard This Week
The Motley Fool • Eric Volkman
Why AI Stock Ceva Was Sliding Hard This Week

11/21/2025 02:33 PM • Ceva announced a secondary stock offering of 3 million shares at $19.50 per share, causing its stock price to drop over 22% for the week due to potential shareholder dilution.

CEVA - Stock price dropped significantly after announcing a new share issuance that could dilute existing shareholders' value, with potential concerns about the company's financial strategy
#AI #stock offering #capital raise #shareholder dilution
Read More
HII Completes Acceptance Trials for Destroyer Ted Stevens (DDG 128)
GlobeNewswire Inc. • Hii
HII Completes Acceptance Trials for Destroyer Ted Stevens (DDG 128)

11/21/2025 02:00 PM • Ingalls Shipbuilding successfully completed sea trials for the Arleigh Burke-class guided missile destroyer Ted Stevens (DDG 128), demonstrating mission capabilities and preparing for U.S. Navy delivery.

HII - Successfully completed sea trials, highlighted team's skill and achievement in building advanced warships, and demonstrated continued progress in naval shipbuilding
#destroyer #sea trials #naval shipbuilding #Arleigh Burke-class #U.S. Navy
Read More
Primo Brands Corporation (PRMB) Faces Securities Class Action Amid Botched Integration, CEO Departure -- Hagens Berman
GlobeNewswire Inc. • Hagens Berman
Primo Brands Corporation (PRMB) Faces Securities Class Action Amid Botched Integration, CEO Departure -- Hagens Berman

11/21/2025 01:55 PM • Primo Brands Corporation faces a securities class action lawsuit alleging misleading statements about its merger with BlueTriton Brands, with CEO Robbert Rietbroek departing after revealing significant integration challenges and reduced revenue forecasts.

PRMB - Company experienced significant merger integration problems, reduced revenue forecasts, CEO departure, and stock price dropped 36% after revealing operational disruptions
#securities lawsuit #merger #integration #revenue forecast #CEO departure
Read More
Deadline Alert: Synopsys, Inc. (SNPS) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
GlobeNewswire Inc. • Glancy Prongay & Murray Llp
Deadline Alert: Synopsys, Inc. (SNPS) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

11/21/2025 01:54 PM • Synopsys faces a class action lawsuit alleging misleading statements about its business performance, with shareholders urged to file a lead plaintiff motion by December 30, 2025, following a significant stock price drop after reporting underperforming IP business results.

AAPL - Traded flat with mixed signals of iPhone 17 optimism and weaker demand in China
SNPS - Company reported a 43% year-over-year decline in net income, missed revenue guidance, experienced a 7.7% decline in Design IP segment revenues, and saw its stock price drop 35.8% after revealing business underperformance
#securities fraud #class action #investor lawsuit #financial disclosure
Read More
DEADLINE ALERT for FUN, TLX, LRN, PRMB: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions
GlobeNewswire Inc. • Law Offices Of Howard G. Smith
DEADLINE ALERT for FUN, TLX, LRN, PRMB: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions

11/21/2025 01:52 PM • Law Offices of Howard G. Smith alerts investors about potential securities fraud class action lawsuits for multiple companies, highlighting alleged misleading statements and financial misrepresentations across various industries.

NVDA - Rose almost 1% after announcing plans to supply over 260,000 AI chips to South Korean companies
FUN - Allegations of chronic underinvestment in parks, deferring maintenance, and making misleading statements about operational capabilities and financial prospects
#securities fraud #class action #shareholder lawsuit #investor protection
Read More
3 Forces That Should Drive Investments in 2026
Investing.com • Dave Kovaleski
3 Forces That Should Drive Investments in 2026

11/21/2025 01:45 PM • Goldman Sachs predicts the S&P 500 will reach 7,600 in 2026, driven by potential rate cuts, AI investments, and increased mergers and acquisitions activity.

FSLR - Topped S&P 500 leaderboard with stronger-than-expected earnings and raised guidance
NVDA - Expected to continue strong AI capital expenditure investments
#rate cuts #artificial intelligence #mergers and acquisitions #investment outlook
Read More
US Equities Show Signs of Stabilizing While Yield Compression Supports Risk
Investing.com • Itai Smidt
US Equities Show Signs of Stabilizing While Yield Compression Supports Risk

11/21/2025 01:37 PM • US markets showed signs of recovery after a volatile week, with dovish Federal Reserve signals and expectations of a December rate cut supporting investor sentiment. Tech stocks experienced a pullback, while healthcare and retail sectors demonstrated resilience.

NFLX - Climbed 3.5% and announced a 10-for-1 stock split
NVDA - Despite strong Q3 results, stock dropped 5.5% as investors questioned AI capital expenditure sustainability
#Federal Reserve #rate cut #AI stocks #market correction #healthcare #retail
Read More
Enrollment Drop, Compliance Allegations Fuel Stride (LRN) Shareholder Lawsuit-- Hagens Berman
GlobeNewswire Inc. • Hagens Berman
Enrollment Drop, Compliance Allegations Fuel Stride (LRN) Shareholder Lawsuit-- Hagens Berman

11/21/2025 01:36 PM • Stride Inc., an online educational services provider, faces a securities class action lawsuit alleging fraudulent practices including inflated enrollment numbers, non-compliance with educational regulations, and misleading investors about company performance.

LRN - Accused of multiple unethical practices including inflating student enrollments, ignoring compliance requirements, suppressing whistleblowers, and misrepresenting company performance. Stock price declined significantly after revelations of operational challenges and potential fraud.
#EdTech #securities fraud #enrollment manipulation #investor lawsuit
Read More
Smithfield Foods Donates 32,000 Pounds of Protein to Hampton Roads Foodbanks at the Mayflower Marathon
GlobeNewswire Inc. • Ray Atkinson
Smithfield Foods Donates 32,000 Pounds of Protein to Hampton Roads Foodbanks at the Mayflower Marathon

11/21/2025 12:49 PM • Smithfield Foods donated 32,000 pounds of protein to the Mayflower Marathon Holiday Food and Fund Drive, supporting the Virginia Peninsula Foodbank and Foodbank of Southeastern Virginia. The donation will provide 128,000 food servings to neighbors experiencing hunger in Southeastern Virginia.

WEN - 5%+ dividend yield, global expansion plans, growing digital sales, potential for margin expansion
SFD - Company demonstrated corporate social responsibility by donating significant protein quantities to local foodbanks and supporting community hunger relief efforts
#food donation #hunger relief #protein #foodbank #holiday drive
Read More
Metal Recycling and Recovery Market Size to Hit USD 957.06 Billion by 2035
GlobeNewswire Inc. • Towards Chemical And Materials
Metal Recycling and Recovery Market Size to Hit USD 957.06 Billion by 2035

11/21/2025 12:47 PM • The global metal recycling market is projected to grow from $571.57 billion in 2025 to $957.06 billion by 2035, driven by sustainability demands, technological advancements, and increasing recycling of critical metals for electric vehicles and renewable energy.

JBLU - Cost-cutting initiatives, positive Q3 unit revenue, new route expansions, and fleet modernization
NUE - North America's largest steel producer using internal scrap recycling, aligned with sustainable manufacturing practices
#metal recycling #circular economy #sustainability #electric vehicles #battery metals
Read More
aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug’s Efficacy Moves Forward -- Hagens Berman
GlobeNewswire Inc. • Hagens Berman
aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug’s Efficacy Moves Forward -- Hagens Berman

11/21/2025 12:46 PM • aTyr Pharma reported a wider-than-expected quarterly loss and is facing a securities class action lawsuit after its Phase 3 clinical trial for Efzofitimod failed to meet primary endpoints, causing an 83% stock price drop.

ATYR - Company experienced significant stock price decline, missed financial estimates, failed clinical trial, and is now facing investor litigation over alleged misleading statements about drug efficacy
#clinical trials #securities litigation #pharmaceutical #drug development #FDA
Read More
BCC Research Launches New Model Context Protocol (MCP) Connections, Unlocking Instant Access to Proprietary Market Data
GlobeNewswire Inc. • Scott Hall, Ryan Brothwell
BCC Research Launches New Model Context Protocol (MCP) Connections, Unlocking Instant Access to Proprietary Market Data

11/21/2025 12:43 PM • BCC Research introduced a new Model Context Protocol (MCP) that enables instant, secure access to market intelligence data through AI-powered servers, allowing businesses to integrate verified research directly into their AI systems.

GOOG - Mentioned as supporting MCP technology without specific details about their implementation
#AI #market intelligence #MCP #data integration #enterprise AI
Read More
Transaction in Own Shares
GlobeNewswire Inc. • Shell Plc
Transaction in Own Shares

11/21/2025 12:37 PM • Shell plc announced its ongoing share buy-back programme, purchasing 749,814 shares on the London Stock Exchange and 748,549 shares on the Amsterdam Stock Exchange, with Merrill Lynch International executing independent trading decisions.

SHEL - The company is executing a routine share buy-back programme as part of standard financial management, with no indication of significant positive or negative market impact
#share buy-back #stock repurchase #market regulations #trading
Read More
Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients
GlobeNewswire Inc. • Patrick Gaynes
Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients

11/21/2025 12:35 PM • Pasithea Therapeutics reported positive pharmacokinetic data for its PAS-004 tablet in a Phase 1/1b trial for neurofibromatosis type 1 (NF1) patients, demonstrating linear dose-proportionality and improved tablet formulation characteristics.

KTTA - Reported favorable pharmacokinetic data showing linear dose response, improved tablet formulation, and potential for lower dosing with consistent exposure
#PAS-004 #MEK inhibitor #neurofibromatosis #pharmacokinetics #clinical trial
Read More
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/21/2025 12:00 PM • A class action lawsuit has been filed against aTyr Pharma alleging false and misleading statements about the efficacy of their drug Efzofitimod during the period of January 16-September 12, 2025.

BHC - Carrying past baggage, but has diversified portfolio, stable cash flows, and potential for debt refinancing
ATYR - The lawsuit alleges the company made materially false statements about their drug's capabilities, potentially misleading investors and causing financial harm
#class action #securities lawsuit #investor alert #drug efficacy
Read More
FTNT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortinet, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
FTNT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortinet, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/21/2025 12:00 PM • A class action lawsuit has been filed against Fortinet, alleging the company made false and misleading statements about its FortiGate unit upgrades and projected business revenue between November 2024 and August 2025.

MLCO - Positioned to benefit from China's economic reopening, low P/S ratio, potential 20-30% revenue growth as tourism normalizes
FTNT - The lawsuit alleges the company made materially false statements about its business performance, product upgrades, and revenue projections, suggesting potential securities fraud and misrepresentation of company prospects
#class action #securities lawsuit #investor alert #false statements
Read More
MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/21/2025 12:00 PM • A class action lawsuit has been filed against Marex Group plc alleging false financial statements, undisclosed conflicts of interest, and misleading public statements during the period of May 16, 2024 to August 5, 2025.

MRX - The lawsuit alleges multiple serious financial irregularities including selling over-the-counter financial products to itself, creating conflicts of interest, and having unreliable financial statements that misled investors
#class action #securities fraud #financial misconduct #investor lawsuit
Read More
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/21/2025 12:00 PM • A class action lawsuit has been filed against Baxter International alleging systemic defects in their Novum LVP medical devices that potentially caused patient injuries and deaths, with claims of misleading investor communications.

BAX - The lawsuit alleges serious product defects in medical devices, potential patient harm, inadequate remedial actions, and misleading statements to investors, which significantly damages the company's reputation and potential financial standing
#class action #securities lawsuit #medical device #investor alert
Read More
FLYY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Spirit Aviation Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
FLYY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Spirit Aviation Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/21/2025 12:00 PM • A class action lawsuit has been filed against Spirit Aviation Holdings, alleging false financial statements and potential bankruptcy risk during the period of May 28-August 29, 2025.

GOOGL - Reported 12% revenue growth in Google Services, 34% growth in Google Cloud, increased operating income, strong AI momentum, and received price target upgrades from analysts
FLYYQ - The lawsuit alleges the company made materially false statements about its financial condition, was at risk of being unable to meet debt obligations, and potentially facing imminent bankruptcy, which strongly indicates significant financial distress
#class action #securities lawsuit #financial disclosure #bankruptcy risk
Read More
WPP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that WPP plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc
WPP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that WPP plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/21/2025 12:00 PM • A class action lawsuit has been filed against WPP plc alleging false and misleading statements about its media operations during the period of February 27, 2025 to July 8, 2025, claiming the company concealed material adverse facts about its market performance.

WPP - The lawsuit alleges the company made false statements, concealed adverse market conditions, was losing market share, and misled investors about its business operations and prospects
#class action #securities lawsuit #investor alert #media operations
Read More
FLY Investors Have Opportunity to Lead Firefly Aerospace Inc. Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire Inc. • The Schall Law Firm
FLY Investors Have Opportunity to Lead Firefly Aerospace Inc. Securities Fraud Lawsuit with the Schall Law Firm

11/21/2025 11:00 AM • The Schall Law Firm filed a class action lawsuit against Firefly Aerospace for alleged securities law violations during its IPO period, claiming the company made false and misleading statements about its business growth and commercial viability.

FLY - The lawsuit alleges the company made false statements about its growth potential, spacecraft solutions business, and Alpha rocket program, suggesting intentional misrepresentation of its commercial prospects
#securities fraud #class action lawsuit #IPO #aerospace #investor rights
Read More
Oncology Biomarker Market Accelerates Toward USD 113.5 Billion by 2034
GlobeNewswire Inc. • Towards Healthcare
Oncology Biomarker Market Accelerates Toward USD 113.5 Billion by 2034

11/21/2025 11:00 AM • The global oncology biomarker market is projected to grow from USD 34.16 billion in 2024 to USD 113.54 billion by 2034, with a 12.73% CAGR, driven by precision medicine, technological advances, and increasing cancer incidence.

RHHBY - Highlighted as a key player across multiple value chain segments with strong R&D, clinical trials, and patient support capabilities
#oncology biomarkers #precision medicine #cancer diagnostics #next-generation sequencing #liquid biopsy
Read More
LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire Inc. • The Schall Law Firm
LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit with the Schall Law Firm

11/21/2025 11:00 AM • The Schall Law Firm is pursuing a class action lawsuit against Stride, Inc. for alleged securities fraud, claiming the company made false statements about enrollment numbers, staffing practices, and compliance requirements during the period of October 22, 2024 to October 28, 2025.

LRN - The lawsuit alleges multiple serious misconduct issues including inflating enrollment numbers with 'ghost students', exceeding statutory staffing limits, failing background checks, and suppressing whistleblower reports to improve profit margins
#securities fraud #class action lawsuit #enrollment manipulation #compliance violation
Read More
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire Inc. • The Schall Law Firm
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

11/21/2025 10:50 AM • The Schall Law Firm is pursuing a class action lawsuit against Telix Pharmaceuticals for allegedly making false and misleading statements about its prostate cancer therapeutic candidates and supply chain between February and August 2025.

TLX - The company is accused of overstating its progress with therapeutic candidates and artificially inflating the quality of its supply chain, which led to potential investor damages
#securities fraud #class action lawsuit #investor rights #misleading statements
Read More
BK Virus Infection Market Trends, Strategies and Business Prospects 2025-2035 - Lack of FDA-Approved Drugs Spurs Innovation in BK Virus Treatment
GlobeNewswire Inc. • Researchandmarkets.Com
BK Virus Infection Market Trends, Strategies and Business Prospects 2025-2035 - Lack of FDA-Approved Drugs Spurs Innovation in BK Virus Treatment

11/21/2025 10:50 AM • The BK virus infection market is experiencing growth due to increasing organ transplant procedures, lack of FDA-approved drugs, and rising awareness. Innovative therapies and personalized medicine approaches are emerging to address treatment challenges.

VERA - Mentioned in company profiles with no specific details about their current developments
#BK virus #organ transplant #immunotherapy #antiviral drugs #precision medicine
Read More